STOCK TITAN

Cinemark Holdings, Inc. (CNK) Financials

CNK
Trailing 12 months to March 31, 2026
Revenue $3.2B +6.9% YoY
Net Income $170.7M -30.6% YoY
EPS (Diluted) $1.24 -18.4% YoY
Free Cash Flow Not reported for the trailing 12 months
Market Cap $4.2B as of Oct 10, 2026
Price / Sales 1.3x on $3.2B revenue, trailing 12 months to March 31, 2026
Price / Earnings 24.7x on $170.7M net income, trailing 12 months to March 31, 2026
Price / Book n/m no shareholder equity reported

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CNK SEC filings page.

Cinemark Holdings, Inc. (CNK) reported $3.2B in revenue over the twelve months to Mar 31, 2026, up 6.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CNK FY2025

Revenue recovery has largely arrived, but earnings remain highly sensitive to costs below the top line.

Revenue was essentially flat from FY2024 to FY2025 while net margin compressed from 10.2% to 4.4%, indicating that the latest earnings decline came from weaker conversion of sales into profit rather than a major top-line contraction. This pattern makes profitability less resilient than revenue alone suggests.

FY2021 liabilities were $4.9B and debt-to-equity was 7.7x; the capital structure therefore relied heavily on creditors, leaving reported returns more sensitive to modest changes in earnings.

In FY2021, operating cash flow was $166M while free cash flow was $71M, so cash generation remained positive despite the period’s accounting loss. Depreciation of $265M helps explain why cash and earnings diverged, showing that reported cash generation was not simply a mirror of profitability.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Cinemark Holdings, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$643.1M
YoY+18.9%
QoQ-17.2%
5Y CAGR+41.2%
10Y CAGR-0.9%

Cinemark Holdings, Inc. generated $643.1M in revenue in Q1 2026. This represents an increase of 18.9% from the same quarter a year earlier. Against the prior quarter it is down 17.2%.

Net Income
-$6.4M
YoY+83.5%
QoQ-118.8%

Cinemark Holdings, Inc. reported -$6.4M in net income in Q1 2026. This represents an increase of 83.5% from the same quarter a year earlier. Against the prior quarter it is down 118.8%.

EPS (Diluted)
-$0.06
YoY+81.3%
QoQ-122.2%

Cinemark Holdings, Inc. earned -$0.06 per diluted share (EPS) in Q1 2026. This represents an increase of 81.3% from the same quarter a year earlier. Against the prior quarter it is down 122.2%.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Dividends Per Share
$0.09
YoY+12.5%
QoQ0.0%

Cinemark Holdings, Inc. paid $0.09 per share in dividends in Q1 2026. This represents an increase of 12.5% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
Diluted avg 115M

Cinemark Holdings, Inc. had a weighted average of 115M diluted shares in Q1 2026; the shares outstanding count is not reported for that period.

Free Cash Flow

Not reported for Q1 2026.

Cash & Debt

Not reported for Q1 2026.

Margins & Returns

Net Margin
-1.0%
YoY+6.2pp
QoQ-5.4pp
10Y change-9.3pp

Cinemark Holdings, Inc.'s net profit margin was -1.0% in Q1 2026, showing the share of revenue converted to profit. This is up 6.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.4 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Return on Equity

Not reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

CNK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNK quarterly income statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-Q
Revenue$643.1M+18.9%$776.3M-4.7%$857.5M-7.0%$940.5M+28.1%$540.7M-6.6%$814.3M+27.5%$921.8M+5.4%$734.2M-22.1%
Interest Expense$34.7M-9.9%$32.2M-8.0%$32.2M-12.3%$39.4M+13.9%$38.5M+2.1%$35.0M+113.3%$36.7M-3.7%$34.6M-6.7%
Net Income-$6.4M+83.5%$34.1M-33.5%$49.5M-73.6%$93.5M+104.1%-$38.9M-256.9%$51.3M+385.0%$187.8M+108.2%$45.8M-61.5%
EPS (Basic)-$0.06+81.3%$0.30-30.2%$0.43-72.1%$0.81+118.9%-$0.32-260.0%$0.43+386.7%$1.54+108.1%$0.37-62.2%
EPS (Diluted)-$0.06+81.3%$0.27-18.2%$0.40-66.4%$0.63+96.9%-$0.32-268.4%$0.33+466.7%$1.19+95.1%$0.32-60.0%
Diluted Shares (Avg)115M-3.9%N/A124M-21.7%149M-2.8%119M-21.7%N/A158M+4.1%153M+1.1%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Income Tax.

CNK Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNK quarterly balance sheet
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-Q
Cash & EquivalentsN/A$0N/AN/AN/A$0-100.0%$0-100.0%N/A
Short-Term InvestmentsN/A$0N/AN/AN/A$0$0N/A
Long-Term InvestmentsN/A$0N/AN/AN/A$0$0N/A
Goodwill$1.2B+0.4%$1.2B+0.5%$1.2B+0.1%$1.2B+0.1%$1.2B-0.5%$1.2B-0.9%$1.2B-0.3%$1.2B-1.0%

Not reported in any period shown, so not listed: Total Assets, Current Assets, Inventory, Accounts Receivable, Total Liabilities, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Total Equity, Retained Earnings.

CNK Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNK quarterly cash flow statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-Q
Depreciation & Amortization$51.6M+4.2%$52.1M+5.9%$50.9M+3.7%$49.4M-0.8%$49.5M+0.2%$49.2M-1.4%$49.1M-5.4%$49.8M-5.7%
Stock-Based Compensation-$8.7M-6.1%N/A-$10.3M-22.6%-$7.6M+18.3%-$8.2M-28.1%N/A-$8.4M-31.3%-$9.3M-236.8%

Not reported in any period shown, so not listed: Operating Cash Flow, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

CNK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNK quarterly financial ratios
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-Q
Net Margin-1.0%+6.2pp4.4%-1.9pp5.8%-14.6pp9.9%+3.7pp-7.2%-11.5pp6.3%+9.1pp20.4%+10.1pp6.2%-6.4pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Return on Equity, Return on Assets, Current Ratio, Debt-to-Equity, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Cinemark Holdings, Inc. CNK FY2025 $3.1B $138.2M 4.4% $4.2B —
Atlanta Braves Holdings, Inc. Series A BATRA FY2025 $732.5M -$23.4M -3.2% $3.7B 26/100
iQIYI, Inc. IQ FY2025 $3.9B -$29.5M -0.8% $984.3M 26/100
Atlanta Braves Holdings, Inc. Series C BATRK FY2025 $732.5M -$23.4M -3.2% $3.3B 26/100
Sphere Entertainment Co. SPHR FY2025 $1.2B $33.4M 2.7% $3.8B 34/100

Frequently Asked Questions

What is Cinemark Holdings, Inc.'s annual revenue?

Cinemark Holdings, Inc. (CNK) reported $3.1B in total revenue for fiscal year 2025. This represents a 2.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cinemark Holdings, Inc.'s revenue growing?

Cinemark Holdings, Inc. (CNK) revenue grew by 2.1% year-over-year, from $3.0B to $3.1B in fiscal year 2025.

Is Cinemark Holdings, Inc. profitable?

Yes, Cinemark Holdings, Inc. (CNK) reported a net income of $138.2M in fiscal year 2025, with a net profit margin of 4.4%.

Cinemark Holdings, Inc. (CNK) reported diluted earnings per share of $1.04 for fiscal year 2025. This represents a -49.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cinemark Holdings, Inc. (CNK) had a net profit margin of 4.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Cinemark Holdings, Inc. (CNK) paid $0.33 per share in dividends during fiscal year 2025.

Cinemark Holdings, Inc. (CNK) trades at 24.7x earnings, its market capitalization divided by net income of $170.7M net income, trailing 12 months to March 31, 2026. The market capitalization is $4.2B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Cinemark Holdings, Inc. (CNK) trades at 1.3x sales, its market capitalization divided by revenue of $3.2B revenue, trailing 12 months to March 31, 2026. The market capitalization is $4.2B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Back to top